Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
> Pharma China Web Edition
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Industry News
11/27/2023
Coherus Sets Price of China-Made PD-1 Inhibitor Loqtorzi at a 20% Disc...
11/27/2023
AstraZeneca to open Hong Kong R&D centre by late 2024 at earliest with...
11/26/2023
Dizal Strikes Derma Drug JV Deal with Wuxi High-tech Zone
11/26/2023
Zhifei to Acquire Chenan to Expand into Metabolic Disease Drugs
11/23/2023
Myricx Concludes Global Licence Deal for WuXi Bio's Antibody
11/22/2023
Acrometa to Strengthen Biopharma Presence in China by Developing Co-Wo...
(Free)
11/21/2023
Tencent Sets Sights on China's Multibillion-Dollar Healthcare Sector w...
11/21/2023
Bimeda Opens £22M China Plant
11/21/2023
Connect Bio and Simcere Pharma Announce Exclusive License Deal for Rad...
11/21/2023
AstraZeneca and Usynova Strike Global License Deal for KRASG12D Inhib...
11/21/2023
BeiGene and Ensem Therapeutics Announce Partnership to Advance Differe...
11/21/2023
MNCs Unveil Initiatives at CIIE to Deepen Connection with Chinese Pati...
11/20/2023
Aurobindo Pharma's China Plant Gets EU's GMP Approval
(Free)
11/20/2023
Chiesi Signs License Deal with Haisco for a Novel, Reversible DPP1 In...
11/20/2023
Roche to Further Explore China's Personalized Healthcare Market Poten...
11/16/2023
Daewoong Inks MOU with Meheco International to Boost Drug Export to Ch...
11/13/2023
MSD Takes Over AstraZeneca as the Top MNC in China Q3/2023
11/13/2023
Boehringer Ingelheim and ChromX Health Join Hands to Research Lung Dis...
11/13/2023
Nona Announces Strategic Collaboration with GeneQuantum for Early Disc...
11/13/2023
Novartis, Legend Enter Global License Deal for Certain CAR-T Therapies...
11/9/2023
AstraZeneca Reports Q3/2023 Performance with Dwindling China Revenue G...
11/9/2023
BeiGene and Zymeworks Terminate Partnership on Bi-specific ADC Drug ZW...
11/9/2023
AstraZeneca Licenses Eccogene's Novel Agent for Cardiometabolic Condit...
11/8/2023
Chinese and Foreign Pharma, MedTech Firms Discuss Cooperation at CIIE
11/8/2023
Menarini Group Out-Licenses Orserdu to SciClone in China
11/7/2023
Moderna Begins Construction of First China Plant during CEO's Visit fo...
11/7/2023
Bayer Join Hands with Shanghai Pharma for Its Co.Lab Incubator Network...
11/7/2023
WuXi XDC Eyes Up to $471M in Hong Kong IPO
11/7/2023
Senti Bio Announces New Strategic Collaboration with Celest Therapeuti...
11/6/2023
486 A-Listed MedPharma Cos Report Performance in First Three Quarters ...
Page:
6
/
13
Total number of articles:
370
:
[First]
[<<]
[4]
[5]
[6]
[7]
[8]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit